Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid (2024)
- Authors:
- Zahm, Shelia
- Bonde, Jens Peter
- Chiu, Weihsueh A
- Hoppin, Jane
- Kanno, Jun
- Abdallah, Mohamed
- Blystone, Chad R
- Calkins, Miriam M
- Dong, Guang Hui
- Dorman, David C
- Fry, Rebecca
- Guo, Huan
- Haug, Line Småstuen
- Hofmann, Jonathan N.
- Iwasaki, Motoki
- Machala, Miroslav
- Mancini, Francesca Romana
- Maria-Engler, Silvya Stuchi
- Møller, Peter Rsak
- Ng, Jack Chakmeng
- Pallardy, Marc
- Post, Gloria B
- Salihovic, Samira
- Schlezinger, Jennifer
- Soshilov, Anatoly
- Steenland, Kyle
- Steffensen, Inger Lise
- Tryndyak, Volodymyr
- White, Alexandra
- Woskie, Susan
- Zahm, Shelia
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- DOI: 10.1016/S1470-2045(23)00622-8
- Subjects: CARCINOGÊNESE; PRODUTOS QUÍMICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: The Lancet Oncology
- ISSN: 1470-2045
- Volume/Número/Paginação/Ano: v. 25, n. 1, p. 16-17, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZAHM, Shelia et al. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, v. 25, n. 1, p. 16-17, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/S1470-2045(23)00622-8. Acesso em: 22 jan. 2026. -
APA
Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. The Lancet Oncology, 25( 1), 16-17. doi:10.1016/S1470-2045(23)00622-8 -
NLM
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2026 jan. 22 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8 -
Vancouver
Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, Blystone CR, Calkins MM, Dong GH, Dorman DC, Fry R, Guo H, Haug LS, Hofmann JN, Iwasaki M, Machala M, Mancini FR, Maria-Engler SS, Møller PR, Ng JC, Pallardy M, Post GB, Salihovic S, Schlezinger J, Soshilov A, Steenland K, Steffensen IL, Tryndyak V, White A, Woskie S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid [Internet]. The Lancet Oncology. 2024 ; 25( 1): 16-17.[citado 2026 jan. 22 ] Available from: https://dx.doi.org/10.1016/S1470-2045(23)00622-8 - Artepillin C induces selective oxidative stress and inhibits migration and invasion in a comprehensive panel of human cervical cancer cell lines
- Epiderme equivalente para estudos de fotoproteção in vitro
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- REPIN-1 as a tumoral marker in cervical cancer
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- Autofagia para a sobrevivência
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma
- The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies
- Novel kojic acid derivatives ACT on melanogenesis and skin age-related enzymes
- Resenha sem título próprio
Informações sobre o DOI: 10.1016/S1470-2045(23)00622-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
